journal article·2024-12-31Open access

Panicum maximum Jacq. mediated green synthesis of silver nanoparticles: synthesis, characterization, and biological activities supported by molecular docking

Heba W. Alhamdi, Hanan Khalaf Anazi, Fatma Alzahraa Mokhtar, Seham S. Elhawary, Serag Eldin I. Elbehairi, Mohammad Y. Alfaifi, Ali A. Shati, Lamiaa I. Fahmy, Engy Elekhnawy, Afnan Hassan, Walaa A. Negm, Sherif Ashraf Fahmy, Nabil Selim

Abstract

This study uses the aerial parts of Panicum maximum total extract (PMTE) to synthesize silver nanoparticles (AgNPs) in an environmentally friendly manner. TEM, SEM, FTIR, X-ray powder diffraction (XRD), Zeta potential, UV, and FTIR were used to characterize the green silver nanoparticles (PM-AgNPs). PM-AgNPs were evaluated as anticancer agents compared to (PMTE) against breast (MCF-7), lung (A549), and ovary adenocarcinoma (SKOV3) human tumour cells. The antibacterial activity of AgNPs was assessed against Staphylococcus aureus isolates. The PM-AgNPs had an absorbance of 418 nm, particle size of 15.18 nm, and zeta potential of −22.4 mV, ensuring the nanosilver’s stability. XRD evaluated the crystallography nature of the formed PM-AgNPs. The cytotoxic properties of PM-AgNPs on MCF-7 and SKOV 3 were the strongest, with IC50s of 0.13 ± 0.015 and 3.5 ± 0.5 g/ml, respectively, as compared to A549 (13 ± 3.2 µg/mL). The increase in the apoptotic cells was 97.79 ± 1.61 and 96.6 ± 1.91% for MCF-7 and SKOV3 cell lines, respectively. PM-AgNPs were found to affect the membrane integrity and membrane permeability of 50 and 43.75% of the tested isolates, respectively. Also, PM-AgNPs have recorded a reduction in the biofilm formation of S. aurues. These results suggest using PM-AgNPs to treat breast and ovarian cancers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Moringa oleifera research and applications · Phytochemistry and Bioactivity Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biology, College of Sciences, King Khalid University, Abha 61413, Saudi Arabia

Department of Biology, Collage of Science, Tabuk University, Tabuk, Saudi Arabia

Fujairah Research Centre, Sakamkam Road, Fujairah, United Arab Emirates

Department of Pharmacognosy, Faculty of Pharmacy, El Saleheya El Gadida University, El Saleheya El Gadida 44813, Sharkia, Egypt

Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Kasr-El-Ainy Street, Cairo 11562, Egypt

Tissue Culture and Cancer Biology Research Laboratory, King Khalid University, Abha, 9004, Saudi Arabia

King Khalid University, Faculty of Science, Biology Department, Abha 9004, Saudi Arabia

Department of microbiology and immunology, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Giza, Egypt

Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt

Biomedical Sciences Program, University of Science and Technology, Zewail City of Science and Technology, Cairo, 12578, Egypt

Department of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt

Department of Chemistry, School of Life and Medical Sciences, University of Hertfordshire Hosted by Global Academic Foundation, R5 New Garden City, New Capital, Cairo 11835, Egypt

Funding

King Khalid University

References (50)

Show source-provided references
1. 10.1039/d3ra08908h10.1039/d3ra08908h ↗
2. 10.3390/agronomy1106107110.3390/agronomy11061071 ↗
3. 10.1007/s12042-011-9081-610.1007/s12042-011-9081-6 ↗
4. 10.3390/ph1511135410.3390/ph15111354 ↗
5. 10.1021/acs.inorgchem.7b0094510.1021/acs.inorgchem.7b00945 ↗
6. 10.3390/polym1506146410.3390/polym15061464 ↗
7. 10.1021/acsomega.1c0429710.1021/acsomega.1c04297 ↗
8. 10.1038/s41598-022-07831-y10.1038/s41598-022-07831-y ↗
9. 10.3934/microbiol.2018.3.48210.3934/microbiol.2018.3.482 ↗
10. 10.1128/CMR.00134-1410.1128/CMR.00134-14 ↗
11. Tam K, Torres V. Staphylococcus aureus secreted toxins & extracellular enzymes Kayan. Physiol Behav. 2016;176:139–148.
12. 10.1038/s41598-023-33988-110.1038/s41598-023-33988-1 ↗
13. 10.3390/catal1305089110.3390/catal13050891 ↗
14. 10.1021/acsapm.2c0109310.1021/acsapm.2c01093 ↗
15. 10.1021/acsomega.2c0639010.1021/acsomega.2c06390 ↗
16. 10.1016/j.nanoso.2024.10114210.1016/j.nanoso.2024.101142 ↗
17. 10.3389/fbioe.2023.117798110.3389/fbioe.2023.1177981 ↗
18. 10.3390/jof810100510.3390/jof8101005 ↗
19. 10.3390/molecules2606172110.3390/molecules26061721 ↗
20. 10.2174/187152062166621090110344010.2174/1871520621666210901103440 ↗
21. 10.3389/fphar.2021.66770410.3389/fphar.2021.667704 ↗
22. Nunez R. DNA measurement and cell cycle analysis by flow cytometry. Curr Issues Mol Biol. 2001;3(3):67–70.
23. 10.1007/978-1-60327-017-5_210.1007/978-1-60327-017-5_2 ↗
24. 10.1016/j.jddst.2023.10482010.1016/j.jddst.2023.104820 ↗
25. 10.3390/pharmaceutics1501001810.3390/pharmaceutics15010018 ↗
26. 10.1007/s42770-021-00485-410.1007/s42770-021-00485-4 ↗
27. 10.1111/jam.1415810.1111/jam.14158 ↗
28. 10.1080/10717544.2022.208372510.1080/10717544.2022.2083725 ↗
29. 10.3390/antibiotics1108099310.3390/antibiotics11080993 ↗
30. 10.1007/s10787-022-01070-310.1007/s10787-022-01070-3 ↗
31. 10.3390/ph1511136110.3390/ph15111361 ↗
32. 10.1016/S0092-8674(00)81717-110.1016/S0092-8674(00)81717-1 ↗
33. 10.1016/j.molcel.2015.10.01310.1016/j.molcel.2015.10.013 ↗
34. 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B ↗
35. 10.1016/j.rinp.2019.10281910.1016/j.rinp.2019.102819 ↗
36. 10.3390/antiox1002027710.3390/antiox10020277 ↗
37. 10.3390/antiox908068110.3390/antiox9080681 ↗
38. 10.1111/tpj.1501010.1111/tpj.15010 ↗
39. 10.3390/nano1007133410.3390/nano10071334 ↗
40. 10.1039/d3ra08779d10.1039/d3ra08779d ↗
41. 10.1007/s40204-023-00219-910.1007/s40204-023-00219-9 ↗
42. 10.4103/joacp.JOACP_349_1510.4103/joacp.JOACP_349_15 ↗
43. 10.1007/s11033-022-07822-210.1007/s11033-022-07822-2 ↗
44. 10.1371/journal.pone.025958410.1371/journal.pone.0259584 ↗
45. 10.3390/pathogens1103030010.3390/pathogens11030300 ↗
46. 10.3389/fmicb.2020.0178410.3389/fmicb.2020.01784 ↗
47. 10.1016/j.bmc.2010.12.04310.1016/j.bmc.2010.12.043 ↗
48. 10.1007/s00280-007-0426-710.1007/s00280-007-0426-7 ↗
49. 10.1016/j.biopha.2019.10908610.1016/j.biopha.2019.109086 ↗
50. 10.1016/j.foodchem.2011.03.07310.1016/j.foodchem.2011.03.073 ↗